Streams

Underreported: Counterfeit Drugs

Thursday, August 19, 2010

Journalist Paula Park discusses the proliferation of counterfeit drugs around the world, and how these fake medications have led to the development of drug-resistant strains of malaria. We’ll find out who’s making and distributing these counterfeit drugs, and more about the efforts being made in Cambodia and other countries to close down illegal outlets. Her article “Lethal Counterfeits” appeared in World Policy Journal’s summer issue.

Guests:

Paula Park
News, weather, Radiolab, Brian Lehrer and more.
Get the best of WNYC in your inbox, every morning.

Comments [2]

Gerald from Urayasu, Japan

Why no mention of the driver of counterfeit drugs: the insane prices of legitimate drugs?

The discussion posited that counterfeiters profit by skimping on ingredients. But ingredients are not necessarily expensive or difficult to obtain. As counterfeiters do avoid the R&D and marketing costs, they could, in theory, produce high quality fakes.

When I lived in Thailand years ago, some local companies produced generics of drugs still under patent protection. When the Thai government faced Western pressure to shut them down, leftists demonstrated in force. asserting the right to produce generics on humanitarian grounds. So the issue is a lot more complicated than, say, the Asian gangs who produce face Louis Vuitton handbags.

Aug. 19 2010 07:35 PM
Phoebe from NJ

How much is this a consequence of US/EU big pharma outsourcing their supply chains to India & China?

Aug. 19 2010 01:51 PM

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.